For subcutaneous administration, 250-500 mcg per day represents the standard range, with some protocols using 300 mcg as a target dose
Treatment of astrocytes with GGC significantly reduced caspase 3 activity (Figure 1B), supporting the protective effects of GGC against oligomeric A 40 -mediated apoptosis
But regulation is not keeping up
Where compatibility has not been established, the substances should not be combined
GHK-Cu supports cellular repair, tissue regeneration, and skin health, making it ideal for those focused on optimizing systemic recovery and skin quality
The tissue under the tongue is thin and densely supplied with blood vessels, allowing GHK-Cu to absorb directly into systemic circulation bypassing the digestive tract and reaching tissues throughout the entire body, not just one localized area